Advanced search
Publication Cover
Neuro-Ophthalmology Volume 41, 2017 - Issue 3
Submit an article Journal homepage
158
Views
23
CrossRef citations to date
0
Altmetric
Case Report

A Case Report of Drug-Induced Myopathy Involving Extraocular Muscles after Combination Therapy with Tremelimumab and Durvalumab for Non-Small Cell Lung Cancer

William CarreraCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA
,
Brandon J. BaartmanCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA
&
Gregory KosmorskyCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USACorrespondence[email protected]
Pages 140-143 | Received 15 Jan 2017, Accepted 01 Feb 2017, Published online: 15 Mar 2017

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Maricruz Anaya-Ruiz & Martin Perez-Santos. (2021) Small-Molecule Inhibitor PD-1/PD-L1 Interaction for Colorectal Cancer Treatment. Pharmaceutical Patent Analyst 10:6, pages 245-250.
Read now
Caberry W Yu, Matthew Yau, Natalie Mezey, Ishraq Joarder & Jonathan A Micieli. (2020) Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review. Eye and Brain 12, pages 139-167.
Read now
Nemesio Villa-Ruano, Tayde Guerrero-González, Eduardo Gómez-Conde & Martin Perez-Santos. (2020) Bispecific anti-PD-L1/PD-1 antibodies for advanced solid tumors: a patent evaluation of US2019010232. Expert Opinion on Therapeutic Patents 30:10, pages 723-727.
Read now
Akshay Badakere & Preeti Patil-Chhablani. (2019) Orbital Apex Syndrome: A Review. Eye and Brain 11, pages 63-72.
Read now
Carlen Yuen, Gini Fleming, Michael Meyers, Betty Soliven & Kourosh Rezania. (2019) Myasthenia gravis induced by avelumab. Immunotherapy 11:14, pages 1181-1185.
Read now
Bahareh Hassanzadeh, Jeffrey DeSanto & Jorge C. Kattah. (2018) Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management. Neuro-Ophthalmology 42:3, pages 176-181.
Read now
Jennifer M Yoest. (2017) Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review. ImmunoTargets and Therapy 6, pages 73-82.
Read now

Articles from other publishers (16)

Rajendra P. Maurya, Kajal Pal, Syeed Mehbub Ul Kadir, Murtuza Nuruddin, Aalok Kumar, Virendra P. Singh, Kokil Tiwari & Vibha Singh. (2023) Orbital apex syndrome: A review. IP International Journal of Ocular Oncology and Oculoplasty 8:4, pages 229-236.
Crossref
A. Martens, P. P. Schauwvlieghe, A. Madoe, I. Casteels & S. Aspeslagh. (2023) Ocular adverse events associated with immune checkpoint inhibitors, a scoping review. Journal of Ophthalmic Inflammation and Infection 13:1.
Crossref
Nika Vrabic, Ana Fakin, Polona Jaki Mekjavic, Urska Janzic, Martina Vrankar & Natasa Vidovic Valentincic. (2022) Various clinical presentations of uveitis associated with durvalumab treatment. Radiology and Oncology 56:2, pages 129-137.
Crossref
Helio V. Neves da Silva, John Placide, Anne Duong, Yasmyne Ronquillo, Shannon McCabe & Majid Moshirfar. (2022) Ocular adverse effects of therapeutic biologics. Therapeutic Advances in Ophthalmology 14, pages 251584142110708.
Crossref
Takshveer Singh, Mortaza Fatehi Hassanabad & Ali Fatehi Hassanabad. (2021) Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188636.
Crossref
Carmen Alba-Linero & Emilio Alba. (2021) Ocular side effects of checkpoint inhibitors. Survey of Ophthalmology 66:6, pages 951-959.
Crossref
Lin Zhou & Xin Wei. (2021) Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer. Frontiers in Immunology 12.
Crossref
Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner & Marc S Ernstoff. (2021) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. Journal for ImmunoTherapy of Cancer 9:6, pages e002435.
Crossref
Blake H. Fortes, Prashant D. Tailor & Lauren A. Dalvin. (2021) Ocular Toxicity of Targeted Anticancer Agents. Drugs 81:7, pages 771-823.
Crossref
Shruthi Harish Bindiganavile, Nita Bhat, Andrew G. Lee, Dan S. Gombos & Nagham Al-Zubidi. (2021) Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review. Journal of Immunotherapy and Precision Oncology 4:1, pages 6-15.
Crossref
Vivian Paraskevi Douglas, Konstantinos A.A. Douglas & Dean M. Cestari. (2019) Immune checkpoint inhibitors. Current Opinion in Ophthalmology 30:6, pages 426-433.
Crossref
Araya Puwanant, Michael Isfort, David Lacomis & Saša A. Živković. (2019) Clinical spectrum of neuromuscular complications after immune checkpoint inhibition. Neuromuscular Disorders 29:2, pages 127-133.
Crossref
Noah A. Kolb, Christopher R Trevino, Waqar Waheed, Fatemeh Sobhani, Kara K. Landry, Alissa A. Thomas & Mike Hehir. (2018) Neuromuscular complications of immune checkpoint inhibitor therapy. Muscle & Nerve 58:1, pages 10-22.
Crossref
Lauren A. Dalvin, Carol L. Shields, Marlana OrloffTakami SatoJerry A. Shields. (2018) CHECKPOINT INHIBITOR IMMUNE THERAPY. Retina 38:6, pages 1063-1078.
Crossref
Shifaa Abdin, Dana Zaher, El-Shaimaa Arafa & Hany Omar. (2018) Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors. Cancers 10:2, pages 32.
Crossref
. (2017) Durvalumab/tremelimumab. Reactions Weekly 1655:1, pages 106-106.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.